Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70...

Area of Science:

• Immunology
• Autoimmunity
• Diagnostic Technologies

Background:

• Antinuclear antibodies (ANA) are key biomarkers for systemic autoimmune connective tissue disorders.
• Indirect immunofluorescence (IIF) on Human epithelial cells-2 (HEp-2) is the gold standard for ANA detection due to its high sensitivity.
• Interpreting complex and mixed ANA patterns on HEp-2, especially the Dense Fine Speckled 70 (DFS70) pattern, poses diagnostic challenges.

Purpose of the Study:

• To introduce a novel engineered HEp-2 IIF substrate for improved ANA pattern interpretation.
• To demonstrate the substrate's ability to confidently differentiate the DFS70 pattern from disease-associated patterns.
• To showcase the substrate's capacity to reveal obscured disease-associated ANA patterns.

Main Methods:

• Development of an engineered HEp-2 IIF substrate.
• Evaluation of the substrate's performance in distinguishing monospecific and mixed ANA patterns, including DFS70.
• Comparison of the novel substrate with conventional HEp-2 substrates for diagnostic accuracy.

Main Results:

• The engineered HEp-2 substrate successfully distinguished the DFS70 pattern with high confidence.
• The substrate effectively differentiated DFS70 from disease-associated patterns like homogeneous and speckled.
• Previously concealed disease-associated ANA patterns were unmasked by the novel substrate.

Conclusions:

• The engineered HEp-2 IIF substrate offers enhanced accuracy in ANA testing.
• This novel substrate aids in the precise diagnosis of autoimmune connective tissue disorders by resolving complex patterns.
• The improved differentiation of DFS70 and other patterns facilitates more reliable clinical interpretation of ANA results.